Что надо знать о редко встречающихся возбудителях инфекций у онкологических больных?

Что надо знать о редко встречающихся возбудителях инфекций у онкологических больных?

Автор: Петухова И.Н., Григорьевская З.В., Багирова Н.С., Агинова В.В.

Журнал: Злокачественные опухоли @malignanttumors

Статья в выпуске: 3S1 т.14, 2024 года.

Бесплатный доступ

Работа посвящена редко встречающимся бактериальным и грибковым возбудителям инфекций. Эти микроорганизмы создают трудности в диагностике и лечении в связи с возможными ошибками идентификации возбудителя, природной или приобретенной лекарственной резистентностью. Возбудители редких инфекций могут колонизировать больных, образовывать биопленки, персистировать в окружающей среде, передаваться от больного к больному и приводить к развитию вспышек инфекции. Они нередко ухудшают прогноз лечения онкологического больного и приводят к летальному исходу. Информация об особенностях редко встречающихся микроорганизмов и возможных подходах к их лечению позволит врачам-онкологам оказывать своевременную квалифицированную помощь подобным пациентам.

Еще

Актиномицеты, нокардии, Mycobacterium tuberculosis, нетуберкулезные микобактерии, криптококки, сахаромицеты, Geotrichum spp., Trichosporon spp., фузарии, сцедоспории, онкологические больные

Короткий адрес: https://sciup.org/140307171

IDR: 140307171   |   DOI: 10.18027/2224-5057-2024-14-3s1-72-79

Список литературы Что надо знать о редко встречающихся возбудителях инфекций у онкологических больных?

  • Mobedi I., Daee-Ghazvini F., Nakhjavani F.A., et al. Actinomyces naeslundii patients with hematological malignancies. Acta Medica Iranica 2006;44(5):345-348.
  • Pierre I., Zarrouk V., Noussar L., et al. . Invasive actinomycosis: a surrogate marker of a poor prognosis in immunocompromised patients. Int J Infect Dis 2014;29:74-79. https://doi.org/10.1016/j.ijid.2014.06.012
  • Dos Santos Menezes A.C., Daltro Borges Alves L., de Assis Ramos G., et al. The multiple presentation of oral actinomycosis in post-hematopoietic stem cell transplantation patients: case series. Hematol Transfus Cell Ther 2023:1-7. https://doi.org/10.1016/j.htct.2023.11.003
  • Бурова С.А. Актиномикоз. РМЖ 2001;3:146-148
  • Чернеховская Н.Е., Бурова С.А., Поваляев А.В. Актиномикоз бронхов и легких. Пульмонология 2008;3:107-109. https://doi.org/10.18093/0869-0189-2008-0-3-107-109
  • Torres H.A., Reddy B.T., Raad I.I., et al. Nocardiosis in cancer patients. Medicine (Baltimore) 2002;81(5):388-97. https://doi.org/10.1097/00005792-200209000-00004
  • Lopes K., Montenegro C., Vilchez J., et al. IMAGES: Nocardia pneumonia - A surprising and rare pulmonary infection mimicking lung cancer. Pulmonology 2022;28(5):415-417. https://doi.org/10.1016/j.pulmoe.2022.03.013
  • Kao H., Tsai C.A., Sun M.H., et al. Nocardia brain abscess in a patient of lung cancer. Int J Clin Med Imaging 2016;3(10):512. https://doi.org/10.4172/2376-0249.1000512
  • Petitgas P., Lesouhaitier M., Boukthir S., et al. Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report. BMC Infect Dis 2022;22:306. https://doi.org/10.1186/s12879-022-07288-4
  • Lee E.K., Kim J., Park D.H., et al. Disseminated nocardiosis caused by Nocardia farcinica in a patient with colon cancer. A case report and literature review. Medicine 2021;100:29(e26682). https://doi.org/10.1097/MD.0000000000026682
  • Yang M., Xu M., Wei W., et al. Clinical findings of 40 patients with nocardiosis: A retrospective analysis in a tertiary hospital. Exp Ther Med 2014;8(1):25-30. https://doi.org/10.3892/etm.2014.1715
  • Al Akhrass F., Hachen R., Mohamed J.A., et al. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis 2011;17(9):1651. https://doi.org/103201/eid1709.101810
  • Cattaneo C., Antoniazzi F., Caira M., et al. Nocardia spp. infections among hematological patients: results of a retrospective multicenter study. Int J Infect Dis 2013:17:e610-e614. https://doi.org/10.1016/j.ijid.2013.01.013
  • Miyaoka C., Nakamoto K., Shirai T., et al. Pulmonary nocardiosis caused by Nocardia exalbida mimickimg lung cancer. Respirology Case Reports 2019;7(7):e00458. https://doi.org/10.1002/rcr2.458
  • Ansari S.R., Safdar A., Han X.Y., O`Brien S. Nocardia veterana bloodstream infection in a patient with cancer and a summary of reported cases. Int J Infect Dis 2006;10(6):483-6. https://doi.org/10.1016/j.ijid.2006.03.005
  • Kmeid J., Kulkarni P.A., Batista M.V., et al. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014. BMC Infect Dis 2019;19(1):934. https://doi.org/10.1186/s12879-019-4586-y
  • Комиссарова О., Михайловский А., Абдуллаев Р. Туберкулез легких и злокачественные новообразования. Врач 2020;2:3-6. https://doi.org/10.29296/25877305-2020-02-01
  • Kamboj M., Sepkowitz K.A. The risk of tuberculosis in patients with cancer. Clin Infect Dis 200. 6;42(11):1592-5. https://doi.org/10.1086/503917
  • Dobler C.C., Cheung K., Nguen J., Martin A. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. Eur Respir J 2017;50(2):1700157. https://doi.org/10.1183/13993003.00157-2017
  • Siewchaisakul P., Nanthanangkul S., Santong C., et al. Survival of cancer patients with co-morbid tuberculosis in Thailand. Asian Pac J Cancer Prev 2021;22(8):2701-2708. https://doi.org/10.31557/APJCP.2021.22.8.2701
  • Kato Y., Watanabe Y., Yamane Y., et al. Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report. Immunotherapy 2020;12(6):373-378. https://doi.org/10.2217/imt-2020-0061
  • Anastasopoulou A., Ziogas D.C., Samarkos M., et al. Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations. J Immunother Cancer 2019;7(1):239-251. https://doi,org/10.1186/s40425-019-0717-7
  • Hirashima T., Tamura Y., Hashimoto S., et al. Efficacy and safety of concurrent anti-cancer and anti-tuberculosis chemotherapy in cancer patients with active Mycobacterium tuberculosis: a retrospective study. BMC Cancer 2018;18(1):975-984. https://doi.org/10.1186/s12885-018-4889-1
  • Tadmori I., Benmiloud S., Habibi M., Hida M. Active tuberculosis in children receiving chemotherapy. Open Journal of Pediatrics 2022;12(1);75-78. https://doi.org/10.4236/ojped.2022.121009
  • Aldabbah M.A., Abughasham A., Alansari G.A., et al. The prevalence of Mycobacterium tuberculosis infection among cancer patients, receiving chemotherapy in a tertiary care center. Cureus 2022;14(11):e32068. https://doi.org/10.7759/cureus.32068
  • Pennington K.M., Vu A., Ghallener D., et al. Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease. J Clin Tub Other Mycobact Dis 2021;24:100244. https://doi.org/10.1016/j.jctube.2021.100244
  • Addisu A., Alok A., Binkam M., et al. Nontuberculous Mycobacterial isolates among cancer patients: A single-center 5-year experience. Infect Dis Clin Practice 2023;31(1):e1195. https://doi.org/10.1097/IPC.0000000000001195
  • Al-Anazi K.A., Al-Jasser A.M., Al-Anazi W.K. Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation. Front Oncol 2014;4:311. https://doi.org/10.3389/fonc.2014.00311
  • Redelman-Sidi G., Sepkowitz K.A. Rapidly growing mycobacteria infection in patients with cancer. Clin Infect Dis 2010;51(4):422-434. https://doi.org/10.1086/655140
  • Yoon H.J., Choi H.Y., Ki M. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea. BMC Infect Dis 2017;17(1):432. https://doi.org/10.1186/s12879-017-2532-4
  • Da Costa A.R.F., Falkinham J.O. 3rd, Lopez M.L., et al. Occurrence of nontuberculosis mycobacterial pulmonary infection in an endemic area of tuberculosis. PLoS Negl Trop Dis 2013;7(7):e2340. https://doi.org/10.1371/journal.pntd.0002340
  • Goswami P.N., Kishore A. Infections with yeast and yeast like fungi in cancer patients with special emphasis on non-neoformans cryptococcal infections: Retrospective study. Indian J Microbiol Res 2019;6(3):213-220. https://doi.org/10.18231/j.ijmr.2019.047
  • Patel V., Desjardins M., Cowan J. Shift in epidemiology of Cryptococcal infections in Ottawa with high-mortality in Non-HIV immunocompromised patients. J Fungi 2019;5(4):104. https://doi.org/10.3390/jof5040104
  • Coussement J., Heath C.H., Roberts M.B., et al. Current epidemiology and clinical features of Cryptococcus infection in patients without human immunodeficiency virus: a multicenter study in 46 hospitals in Australia and New Zealand. Clin Infect Dis 2023;77(7):976-86. https://doi.org/10.1093/cid/ciad321
  • Kontoyiannis D.P., Peitsch W.K., Reddy B.T., et al. Cryptococcosis in patients with cancer. Clin Infect Dis 2001;32(11):е145-50. https://doi.org/10.1086/320524
  • Gangadharan S.S., Raveendranath S. Cryptococcosis in oncology patients: a case series in a tertiary care cancer centre. Iran J Microbiol 2023;15(6):821-825. https://doi.org/10.18502/ijm.v15i6.14163
  • Liu K., Ding H., Xu B., et al. Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis, J Thorac Dis 2016;8(10):2813-2821. https://doi.org/10.21037/jtd.2016.10.36
  • Li H., Guo M., Wang C., et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol Infect 2020;148:e169. https://doi.org/10.1017/S0950268820001624
  • Mehta V., Nayyar C., Gulati N., et al. A comprehensive review of Trichosporon spp.: An Invasive and Emerging Fungus. Cureus 2021;13(8):e17345. https://doi.org/10.77/cureus.17345
  • Montoya A.M., Gonzalez G.M. Trichosporon spp.: an emerging fungal pathogen. Medicina Universitaria 2014:16(62):37-43
  • Abbas A.A., Alamri A.W., Almofti A.H. Trichosporon asahii infection mortality in pediatric oncology patients: a report of six patients. J Microbiol Infect Dis 2020;10(3):167-172. https://doi.org/10.5799/jmid.790293
  • Robles-Tenorio A., Rivas-Lopez R.A., Bonifaz A., Tarango-Martinez V.M. Disseminated mucocutaneous trichosporonosis in a patient with histiocytic sarcoma. An Bras Dermatol 2021;96(5):595-597. https://doi.org/10.1016/j.abd.2021.01.003
  • Байбак О.И., Абугова Ю.Г., Пирумова Р.П. и соавт. Инвазивный микоз, вызванный Trichosporon mucoides. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2017;16(1):49-53. https://doi.org/10.24287/1726-1708-2017-16-1-49-53
  • El Omri H., Fathallah-Mili A., Ben Youssef Y., et al. Geotrichum capitatum septicemia in neutropenic patient, case report and review. Journal de Mycologie Medicale 2005;15(4):242-246. https://doi.org/10.1016/j.mycmed.2005.09.002
  • Gao G.X., Tang H.L., Zhang X., et al. Invasive fungal infection caused by Geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review. Int J Clin Exp Med 2015;8(8):14228-14235.
  • Sulik-Tyszka B., Snarski E., Niedzwiedzka M., et al. Experience of Saccharomyces boulardii probiotic in oncohaematological patients. Probiotics & Antimicro Prot 2018;10(2):350-355. https://doi.org/10.1007/s12602-017-9332-4
  • Enache-Angoulvant A., Hennequin C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 2005;41(11):1559-68. https://doi.org/10.1086/497832
  • Chakravarty S., Parashar A., Acharyya S. Saccharomyces cerevisiae sepsis following probiotic therapy in an infant. Indian Pediatr 2019;56(11):971-972
  • Батманова Н.А., Багирова Н.С., Григорьевская З.В. и соавт. Успешная диагностика и лечение фузариоза у больной острым лейкозом. Гематология и трансфузиология 2022;67(1):139-149. https://doi.org/10.35754/0234-5730-2022-67-1-139-149
  • Nucci M., Anassie E.J., Queiros-Telles F., et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003;98(2):315-319. https://doi.org/10.1002/cncr.11510
  • Hoyos-Pulgarin J.A., Arias-Ramos D., Gonzalez-Diaz J.A., Ramirez N.M. Unusual finding in Gram staining of blood cultures in a patient with prolonged febrile neutropenia and acute myeloid leukemia. Enferm Infecc Microbiol Clin 2020;38(7):338-340. https://doi.org/10.1016/j.eimc.2019.12.015
  • Hayashida M.Z., Seque C.A., Simoes e Silva Enokihara M.M., Porro A.M. Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate. An Bras Dermatol 2018;93(5):726-9. https://doi.org/10.1590/abd1806-4841.20187476
  • Liu Y.S., Wang N.C., Ye R.H., Kao W.Y. Disseminated Fusarium infection in a patient with acute lymphoblastic leukemia: a case report and review of the literature. Oncol Lett 2014;7(2):334-336. https://doi.org/10.3892.ol.2013.1738
  • Tortorano A.M., Prigetano A., Esposto M.C., et al. European Medical Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis 2014;33(9):1623-30. https://doi.org/10.1007/s10096-014-2111-1
  • Ferreira Chagas D., Martins Diniz L., Almeida Lucas E., Emerich Noguera P.S. Disseminated fusariosis in a patient with bone marrow aplasia. An Bras Dermatol 2020;95(5):609-614. https://doi.org/10.1016/j.abd.2019.12.008
  • Marinovic D.A., Bhaimia E., Forrest G.N., et al. Scedosporium infection disseminated “from toe to head ” in allogeneic stem cell transplant recipient: a case report. BMC Infect Dis 2023;23(1):353. https://doi.org/10.1186/s12879-023-08345-2
  • Seidel D., Meissner A., Lackner M., et al. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and Fungiscope®. Crit Rev Microbiol 2019;45(1):1-21. https://doi.org/10.1080/1040841X.2018.1514
  • Goldman C., Akiyama M.J., Torres J., et al. Scedosporium apiospermum and the role of combination antifungal therapy and GM-CSF: a case report and review of the literature. Med Mycol Case Rep 2016;11:40-43. https://doi.org/j.mmcr.2016.04.005
  • Woolhouse M.E. Population biology of emerging and reemerging pathogens. Trends Microbiol 2002;10(10, Suppl.):S3-S7. https://doi.org/10.1016/s0966-842x(02)02428-9.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp